Pieris Pharmaceuticals
PIRS
#10775
Rank
ยฃ13.71 M
Marketcap
ยฃ10.39
Share price
-15.58%
Change (1 day)
N/A
Change (1 year)

Earnings for Pieris Pharmaceuticals (PIRS)

Earnings in 2024 (TTM): -ยฃ17.69 Million

According to Pieris Pharmaceuticals's latest financial reports the company's current earnings are ยฃ19.57 Million. In 2022 the company made an earning of -ยฃ25.42 Million, an increase over its 2021 earnings that were of -ยฃ34.94 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Pieris Pharmaceuticals from 2015 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -ยฃ17.69 Million
2022 -ยฃ25.42 Million-27.24%
2021 -ยฃ34.94 Million23.4%
2020 -ยฃ28.32 Million45.53%
2019 -ยฃ19.46 Million-5.89%
2018 -ยฃ20.68 Million63.59%
2017 -ยฃ12.64 Million-26.92%
2016 -ยฃ17.3 Million63.39%
2015 -ยฃ10.59 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
-ยฃ1.94 Billion 11,350.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
-ยฃ60.64 Million 258.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
-ยฃ4.19 Million-75.20%๐Ÿ‡บ๐Ÿ‡ธ USA